Lebwohl David 4
4 · Intellia Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Lebwohl David
EVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-03$12.18/sh−9,557$116,404→ 87,666 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.